Detalhe da pesquisa
1.
Mapping three-dimensional intratumor proteomic heterogeneity in uterine serous carcinoma by multiregion microsampling.
Clin Proteomics
; 21(1): 4, 2024 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38254014
2.
Survival disparities in non-Hispanic Black and White cervical cancer patients vary by histology and are largely explained by modifiable factors.
Gynecol Oncol
; 184: 224-235, 2024 Feb 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38340648
3.
Racial, ethnic and country of origin disparities in aggressive endometrial cancer histologic subtypes.
Gynecol Oncol
; 184: 31-42, 2024 Jan 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38277919
4.
Disease progression, survival, and molecular disparities in Black and White patients with endometrioid endometrial carcinoma in real-world registries and GOG/NRG oncology randomized phase III clinical trials.
Gynecol Oncol
; 183: 103-114, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38593674
5.
Multi-omic Analysis of Uterine Leiomyomas in Self-Described Black and White Women: Molecular Insights into Health Disparities.
Am J Obstet Gynecol
; 2024 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38723985
6.
CCNE1 and survival of patients with tubo-ovarian high-grade serous carcinoma: An Ovarian Tumor Tissue Analysis consortium study.
Cancer
; 129(5): 697-713, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36572991
7.
Metronomic dosing of ovarian cancer cells with the ATR inhibitor AZD6738 leads to loss of CDC25A expression and resistance to ATRi treatment.
Gynecol Oncol
; 177: 60-71, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37639904
8.
Proteomic alterations associated with residual disease in neoadjuvant chemotherapy treated ovarian cancer tissues.
Clin Proteomics
; 19(1): 35, 2022 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36195845
9.
Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning.
Gynecol Oncol
; 166(1): 90-99, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35624045
10.
Racial disparities in high-risk uterine cancer histologic subtypes: A United States Cancer Statistics study.
Gynecol Oncol
; 161(2): 470-476, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33722415
11.
Racial disparities in survival among women with endometrial cancer in an equal access system.
Gynecol Oncol
; 163(1): 125-129, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34325938
12.
Obesity and altered angiogenic-related gene expression in endometrial cancer.
Gynecol Oncol
; 163(2): 320-326, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34538531
13.
Clinical significance of homologous recombination deficiency score testing in endometrial Cancer.
Gynecol Oncol
; 160(3): 777-785, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33563487
14.
Age and racial differences in the presentation of gestational trophoblastic neoplasia.
Int J Gynecol Cancer
; 31(2): 194-202, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33310882
15.
Sexting: What's Law Got to Do with It?
Arch Sex Behav
; 50(2): 563-573, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32445133
16.
A prognostic system for epithelial ovarian carcinomas using machine learning.
Acta Obstet Gynecol Scand
; 100(8): 1511-1519, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33665831
17.
Genomic heterogeneity in peritoneal implants: A differential analysis of gene expression using nanostring Human Cancer Reference panel identifies a malignant signature.
Gynecol Oncol
; 156(1): 6-12, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31711656
18.
Minority participation in phase 1 gynecologic oncology clinical trials: Three decades of inequity.
Gynecol Oncol
; 157(3): 729-732, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32173047
19.
Long term survival outcomes of stage I mucinous ovarian cancer - A clinical calculator predictive of chemotherapy benefit.
Gynecol Oncol
; 159(1): 118-128, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32828578
20.
Racial disparities in uterine and ovarian carcinosarcoma: A population-based analysis of treatment and survival.
Gynecol Oncol
; 157(1): 67-77, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32029291